Abacavir Sulfate: CAS Registry Number 188062-50-2
Wiki Article
Abacavir sulfate, chemically defined as chemical identifier 188062-50-2, serves as a powerful HIV medication. It inhibits the proliferation of the human immunodeficiency virus (HIV) by stopping the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, enabling the virus to insert its genetic material into the host's DNA. Abacavir sulfate frequently administered in combination with other antiretroviral drugs as part of a comprehensive treatment regimen for HIV infection.
Avastin : Chemical Identifier 183552-38-7
Abarelix, also known by its chemical identifier 183552-38-7, is a/represents/serves as a gonadotropin-releasing hormone (GnRH) antagonist. It functions by/operates through/acts upon blocking the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This ultimately reduces/suppresses/minimizes testosterone production in men, making it a valuable treatment option for prostate cancer. Abarelix is typically administered/delivered/infused as an injection, usually on a monthly basis.
Abiraterone Acetate: Chemical Identity
Abiraterone acetate plays a role a medication utilized in the treatment of prostate cancer. That substance intervenes by suppressing an enzyme known as 17-alpha-hydroxylase/17,20-lyase, which then prevents the synthesis of androgens, the responsible for fueling prostate cancer growth. CAS Registry Number 154229-18-2 serves the unique code of abiraterone acetate, ensuring its accurate identification within research communities.
Chemical Profile: Abacavir Sulfate (CAS 188062-50-2)
Abacavir sulfate, with the chemical identifier CAS 188062-50-2, acts as a vital component in the treatment of HIV infection. This potent antiretroviral agent targets the replication of the human immunodeficiency virus (HIV). Abacavir sulfate falls within the class of nucleoside reverse transcriptase inhibitors (NRTIs).
Its chemical structure consists of a complex arrangement of elements. The molecule presents characteristic traits that contribute to its biological activity and therapeutic efficacy.
Comprehending the chemical profile of abacavir sulfate extends valuable insights into its mechanism of action, pharmacokinetics, and potential effects with other substances.
Pharmaceutical Compound Identification: Abaarelix (CAS 183552-38-7)
Abaarelix, identified by the CAS registry number 183552-38-7, is a significant pharmaceutical compound within the field of medicine. Its ALGESTONE ACETOPHENIDE 24356-94-3 primary functionality revolves around the manipulation of hormone levels, particularly targeting gonadotropin-releasing hormone (GnRH). This distinct mechanism makes Abaarelix valuable in the treatment of various diseases, notably those involving androgen-dependent growth or expansion.
- Studies into Abaarelix have revealed its efficacy in alleviating symptoms associated with prostate cancer, endometriosis, and certain types of infertility.
- Furthermore, the compound's distribution properties have been meticulously evaluated to confirm its safety and tolerability in clinical settings.
As a result, Abaarelix has emerged as a promising therapeutic approach in the modern medical landscape, offering hope and improved quality of life to patients grappling with these challenging conditions.
Structure and Properties of Abiraterone Acetate CAS No. 154229-18-2
Abiraterone acetate, identified by the chemical identifier CAS No. 154229-18-2, is a potent synthetic molecule. It exhibits a complex configuration characterized by a copyright skeleton. This framework encompasses numerous functional groups, contributing to its pharmacological properties.
Abiraterone acetate is a non-copyrightal restrainer of the enzyme 17α-copyrightogenic acute regulatory protein (CYP17A1), which plays a crucial role in the synthesis of androgens, primarily testosterone. By effectively inhibiting CYP17A1, abiraterone acetate reduces androgen production within the body, thus offering potential therapeutic benefits in the management of prostate cancer.
Report this wiki page